EUVIMEDObjevte EUVIMED
Open access

miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer

Wan-Li Duan, Xue-Jie Wang, Ai Guo, Li-Hui Gu, Zhi-Mei Sheng, Hao Luo, Li-Xia Yang, Wen-Hao Wang, Bao-Gang Zhang

Journal of Cancer · 2024 · 15 (17) · 5622-5635

DOI: 10.7150/jca.96608 ↗

At a glance

Journal article in Journal of Cancer, 2024. Written by Wan-Li Duan and 8 co-authors. Institution: Medical Research Center, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China. Cited 20 times so far (Crossref). The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

Author keywords

Keap1-Nrf2 signaling pathwaybreast cancerferroptosismiR-141-3ppaclitaxel resistance

Authors and institutions

  • Medical Research Center, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China.
  • Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261041, China.
  • Department of Pathology, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China.
  • Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, Shandong, China.
  • Department of Medical Oncology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, China.

Cite

APA

Duan, W. L., Wang, X. J., Guo, A., Gu, L. H., Sheng, Z. M., Luo, H., Yang, L. X., Wang, W. H., & Zhang, B. G. (2024). miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. Journal of Cancer, 15(17), 5622-5635. https://doi.org/10.7150/jca.96608

Vancouver

Duan WL, Wang XJ, Guo A, Gu LH, Sheng ZM, Luo H, et al. miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. Journal of Cancer. 2024;15(17):5622-5635. doi:10.7150/jca.96608

BibTeX
@article{Duan2024,
  author = {Duan, Wan-Li and Wang, Xue-Jie and Guo, Ai and Gu, Li-Hui and Sheng, Zhi-Mei and Luo, Hao and Yang, Li-Xia and Wang, Wen-Hao and Zhang, Bao-Gang},
  title = {miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer},
  journal = {Journal of Cancer},
  year = {2024},
  volume = {15},
  number = {17},
  pages = {5622--5635},
  doi = {10.7150/jca.96608}
}
Start for free →